Abstract
THIS is a preliminary report on the metabolism of propranolol1 (I) in several species, including man.
Similar content being viewed by others
Article PDF
References
Crowther, A. F., and Smith, L. H., U.K. Patent No. 994,918.
Howe, R., I.C.I. Ltd., Pharmaceuticals Division (unpublished work).
Bond, P. A., McLoughlin, B. J., and Smith, L. H., U.K. Patent Application 9092/65.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BOND, P. Metabolism of Propranolol (‘Inderal’), a Potent, Specific β-Adrenergic Receptor Blocking Agent. Nature 213, 721 (1967). https://doi.org/10.1038/213721a0
Issue Date:
DOI: https://doi.org/10.1038/213721a0
This article is cited by
-
Substrate specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase for methyl- and nitrobenzaldehydes
European Journal of Drug Metabolism and Pharmacokinetics (2006)
-
Pharmacokinetics of metoprolol and its metabolite ?-OH-metoprolol in healthy, non-smoking, elderly individuals
European Journal of Clinical Pharmacology (1983)
-
Anaesthetic problems associated with the treatment of cardiovascular disease: II. beta-adrenergic antagonists
Canadian Anaesthetists’ Society Journal (1981)
-
Side effects of antiarrhythmic drugs
Naunyn-Schmiedebergs Archiv f�r Pharmakologie (1971)
-
The pharmacodynamics and metabolism of propranolol in man
Pharmacologia Clinica (1970)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.